A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants

Abroad (travel likely)RecruitingPHASE2

Conditions

Gout

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Amicis Research Center, Granada Hills, California, United States

    Contact: Study coordinator (Pascal Dabel, MD)
  • Cohen Medical Center, Thousand Oaks, California, United States

    Contact: Study coordinator (Shariar Cohen-Gadol, MD)
  • Omega Research Group, DeBary, Florida, United States

    Contact: Study coordinator (Kwabena Ayesu, MD)
  • Clinical Research of Central Florida, Lakeland, Florida, United States

    Contact: Study coordinator (Michael Gimness, MD)
  • Panax Clinical Research, Miami, Florida, United States

    Contact: Study coordinator (Robert Perry, MD)
  • Anchor Medical Research, Miami, Florida, United States

    Contact: Study coordinator (Juvenal Martinez, MD)
  • MD Medical Research, Oxon Hill, Maryland, United States

    Contact: Study coordinator (Stephen Ong, MD)
  • Clinical Research Institute of Michigan, Saint Clair Shores, Michigan, United States

    Contact: Study coordinator (Amar Majjhoo, MD)
  • Revival Research Institute, Sterling Heights, Michigan, United States

    Contact: Study coordinator (Syed Husain, MD)
  • Las Vegas Clinical Trials, Las Vegas, Nevada, United States

    Contact: Study coordinator (Alton Walters, MD)
  • Ellipsis Research Group, Brooklyn, New York, United States

    Contact: Study coordinator (Jorge Serje, MD)
  • Drug Trials America, Hartsdale, New York, United States

    Contact: Study coordinator (Michael Gerdis, MD)
  • Shelby Clinical Research, Shelby, North Carolina, United States

    Contact: Study coordinator (Christian Martin, MD)
  • Zenos Clinical Research, Dallas, Texas, United States

    Contact: Study coordinator (Bachar Elsaadi, MD)
  • Epic Medical Research, DeSoto, Texas, United States

    Contact: Study coordinator (Haresh Boghara, MD)
  • Pioneer Research Solutions, Houston, Texas, United States

    Contact: Study coordinator (Francisco Velazquez, MD)
  • DM Clinical Research, Tomball, Texas, United States

    Contact: Study coordinator (Shaikh Ali, MD)